Page 8 - 2021_06-Haematologica-web

https://doi.org/10.3324/haematol.2020.274951
2251 Rationale for the combination of venetoclax and ibrutinib in T-prolymphocytic leukemia Christoph Kornauth et al.
https://doi.org/10.3324/haematol.2020.271304
2257 Stem cell yield and transplantation in transplant-eligible newly diagnosed multiple myeloma patients receiving daratumumab plus borte- zomib/thalidomide/dexamethasone in the phase III CASSIOPEIA study
Cyrille Hulin et al.
https://doi.org/10.3324/haematol.2020.261842
2261 The significance of gradient expression of chromosome region maintenance protein 1 in large cell lymphoma Jithma P. Abeykoon et al.
https://doi.org/10.3324/haematol.2020.278277
2265 Ibrutinib interferes with innate immunity in chronic lymphocytic leukemia patients during COVID-19 infection Stefania Fiorcari et al.
https://doi.org/10.3324/haematol.2020.277392
2269 Derepression of retroelements in acute myeloid leukemia with 3q aberrations Jagoda Mika et al.
https://doi.org/10.3324/haematol.2020.277400
2274 One third of alloantibodies in patients with sickle cell disease transfused with African blood are missed by the standard red blood cell test panel
Lilian A. Boateng et al.
https://doi.org/10.3324/haematol.2021.278451
2277 A phase II study of brentuximab vedotin in patients with relapsed or refractory Epstein-Barr virus-positive and CD30-positive lymphomas Miso Kim et al.
https://doi.org/10.3324/haematol.2021.278301
2281 Dynamic contrast-enhanced magnetic resonance imaging quantification of leukemia-induced changes in bone marrow vascular function Ana L. Gomes et al.
https://doi.org/10.3324/haematol.2020.277269
Case Reports
2287 Non-inhibitory antibodies inducing increased emicizumab clearance in a severe hemophilia A inhibitor patient Annie Harroche et al.
https://doi.org/10.3324/haematol.2021.278579
2291 Post-mortem findings in vaccine-induced thrombotic thombocytopenia Cristoforo Pomara et al.
https://doi.org/10.3324/haematol.2021.279075
Errata Corrige
2294 Inhibitors of poly ADP-ribose polymerase (PARP) induce apoptosis of myeloid leukemic cells: potential for therapy of myeloid leukemia and myelodysplastic syndromes
Terry J Gaymes et al.
https://doi.org/10.3324/haematol.2020.262857
2295 Impact of cytogenetic abnormalities on outcomes of adult Philadelphia-negative acute lymphoblastic leukemia after allogeneic hematopoi- etic stem cell transplantation: a study by the Acute Leukemia Working Committee of the Center for International Blood and Marrow Transplant Research
Aleksandr Lazaryan et al.
https://doi.org/10.3324/haematol.2021.279046
haematologica Journal of the Ferrata Storti Foundation
2246 The TRPV2 channel mediates Ca2+ influx and the Δ9-THC-dependent decrease in osmotic fragility in red blood cells Anouar Belkacemi et al.
Haematologica 2021; vol. 106 no. 8 - August 2021 http://www.haematologica.org/